Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoglycerate mutase 1 pseudogene 4 (PGAM1P4) is classified as a pseudogene in the human genome. Pseudogenes are DNA sequences similar to known genes but are generally non-functional due to mutations or deletions that prevent them from producing functional proteins. There are no documented functions, interactions, or associations with disease for PGAM1P4, and it is not considered a therapeutic target or an active gene product in current biomedical literature[2].\n\n**Key Points**:\n- PGAM1P4 is not a protein-coding gene—it is a pseudogene, and unlike the related functional gene PGAM1, it does not encode an active enzyme or participate in glycolysis[2].\n- There is no evidence for biological activity, disease involvement, drug interaction, or utility as a biomarker.\n- It should not be considered a druggable or therapeutic target; any reference to this as a pharmaceutical target would be incorrect.\n- If your intent is to collect structured data for clinical, biochemical, or pharmacological targeting, this entry is *incorrect* as a target (is_incorrect: true) due to its status as a non-functional pseudogene[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on phosphoglycerate mutase 1 pseudogene 4 (PGAM1P4).